Saint Luke's Cancer Institute — Kansas City, Missouri

Saint Luke's Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Saint Luke's Cancer Institute has participated in 54 clinical trials with 19 currently active.

Therapeutic areas: Metastatic Breast Cancer, HER2-negative Breast Cancer, Breast Neoplasms.

Sponsors: Gilead Sciences, Saint Luke's Health System, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Cancer Institute?

Saint Luke's Cancer Institute has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Cancer Institute conducted?

Saint Luke's Cancer Institute has 54 clinical trials on record, with 19 currently active. Their work covers Metastatic Breast Cancer, HER2-negative Breast Cancer, Breast Neoplasms.

Is Saint Luke's Cancer Institute accredited by Crixeo Health?

Saint Luke's Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.